AMR Kansas City is conducting an investigational Epstein-Barr vaccine trial for participants ages 18 to 30.
Qualified participants must:
be 18 to 30 years old
be in overall good health
meet other study criteria
Qualified participants will receive all study-related care at no cost. Reimbursement is available up to $2,400.00 for study-related time and travel.
If you're interested in learning more about this trial, you can reach out to AMR today by calling 816-643-4153 or visiting their website at amrkansascity.com for more detailed information.
